Produktinformation
- 4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone
- Bms-536924
Applications BMS 536924 is an inhibitor of insulin-like growth factor receptor (IGF1R) kinase and insulin receptor. BMS 536924 was reported to have antitumor activity.
References Wittman, M., et al.: J. Med. Chem., 48, 5639 (2005); Huang, F., et al.: Cancer Res., 69, 161 (2009);